Schedule 13D ownership disclosure
ADAMAS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 00548A106
Event date: 2015-07-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,360,678
- Percent of class
- 23.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-16-095917
- Form type
- SC 13D
- Filer
- Adamas Pharmaceuticals Inc
- CIK
- CIK 1328143
- Filed
- Feb 11, 2016
- Reporting period
- Jul 10, 2015
- Description
- Schedule 13D beneficial ownership